Favipiravir: Patent rejection in Thailand

Favipiravir (or T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is a broad-spectrum antiviral drug used in the treatment of multiple diseases, and is the first drug approved by countries around the world as an emergency option for Covid-19 cases. Thailand’s Department of Intellectual Property (DIP) has since rejected a Thai patent application filed under the compulsory license system for a […]

Vietnam – Circular No. 6959/TB-SHTT to temporarily ease the stringent signatory requirement by Circular No. 13822/TB-SHTT

The Intellectual Property Office of Vietnam (NOIP) has released a new circular, Circular No. 6959/TB-SHTT (“Circular 6959”) in order to temporarily ease the strict requirements in relation to the signatory requirements of the formal documents in relation to patent applications such as powers of attorney, deeds of assignment, etc. submitted to the NOIP previously imposed […]

A second-round victory for brand drug owners against generics who fail to declare relevant patents under Singapore’s patent linkage regime

Proprietors of brand-name drugs may heave another sigh of relief as the Singapore Court of Appeal in Zyfas Medical Co (Sued as a firm) v. Millennium Pharmaceuticals, Inc [2020] SGCA 84 re-affirmed its holding in Millennium Pharmaceuticals, Inc v. Drug Houses of Australia Pte Ltd [2019] SGCA 31 (the DHA decision) rejecting an overly-restrictive interpretation […]

Salient points concerning the law of anticipation in the case of Element Six Technologies Ltd v. IIa Technologies Pte Ltd.

On February 7, 2020, the Singapore High Court reported its decision in the case of Element Six Technologies Ltd v. IIa Technologies Pte Ltd. [2020] SGHC 26, which treated various issues pertaining to novelty, priority date and anticipation. In particular, there are several interesting points in the decision concerning the law of anticipation which will […]

New Singapore Patent Fast Track Programme to Accelerate Patent Prosecution Timeframe

The Intellectual Property Office of Singapore (IPOS) in its continuing effort to expand support to innovators, launched a new programme named the “SG Patent Fast Track”  on 4 May 2020 to replace the existing patent acceleration programmes, namely FinTech Fast Track and Accelerated Initiative for Artificial Intelligence (“AI2”), which ceased on 25 April 2020 and […]

Southeast Asia Update

A roundup of the newsworthy mentions in the Southeast Asian from the first quarter of 2020. Singapore Snagging the headlines in Singapore early March, on top of the COVID-19 coverage, is the nomination of IPOS’ current Chief Executive, Mr Daren Tang, by WIPO’s Coordination Committee, for the position of WIPO Director General. His nomination is […]

Singapore Swings

Following big policy changes in 2019, the time is right to look at IP developments in this fast-evolving country. For the intellectual property field in Singapore, 2019 was an exciting year, with new policies to promote Singapore as an IP hub and legislative reforms leading the charge in opening up new areas of opportunity. For […]

India Update – Patent Infringement

An action for patent infringement in India is not maintainable during the pendency of an appeal against an order revoking the patent. In Novartis AG & Anr. V. Natco Pharma Limited CS (COMM) 229/2019 and I.As. 11304/2019, 11305/2019, the Delhi High Court (the ‘Court’) has clarified that an action for infringement is not maintainable in […]

Singapore Broadens IP links with Japan, China, Russia and Laos

IPOS International (“IPOSI”), the expertise and enterprise engagement arm of the Intellectual Property Office of Singapore (IPOS), recently signed a Memorandum of Understanding (“MOU”) with Japan’s Industrial Property Cooperation Center (IPCC). The MOU envisages providing enhanced patent search and analytical capabilities in both the Japanese and Chinese languages to benefit enterprises in Japan and Singapore […]